Blood · 2009 · 116 citations · 42 references
MedicineMolecular GeneticsOncologyMolecular OncologyOncogenesStem Cell BiologyCancer Stem Cell BiologyCancer Stem CellsStem Cell DifferentiationStem Cell TumorigenicityTumor Suppressor Gene InactivationTumor Suppressor GenesBcr-abl1 Fusion GenePten InactivationPten SignalingStemness RegulationTumor Suppressor LossTumor Suppressor Pathways
The tumor suppressor gene phosphatase and tensin homolog (PTEN) is inactivated in many human cancers. However, it is unknown whether PTEN functions as a tumor suppressor in human Philadelphia chromosome-positive leukemia that includes chronic myeloid leukemia (CML) and B-cell acute lymphoblastic leukemia (B-ALL) and is induced by the BCR-ABL oncogene. By using our mouse model of BCR-ABL-induced leukemias, we show that Pten is down-regulated by BCR-ABL in leukemia stem cells in CML and that PTEN deletion causes acceleration of CML development. In addition, overexpression of PTEN delays the development of CML and B-ALL and prolongs survival of leukemia mice. PTEN suppresses leukemia stem cells and induces cell-cycle arrest of leukemia cells. Moreover, PTEN suppresses B-ALL development through regulating its downstream gene Akt1. These results demonstrate a critical role of PTEN in BCR-ABL-induced leukemias and suggest a potential strategy for the treatment of Philadelphia chromosome-positive leukemia.
42
Jing Li, Clifford Yen, Danny Liaw et al. · Science · 1997 · 4.8K citations
Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN
Vuk Stambolic, Akira Suzuki, José Luís de la Pompa et al. · Cell · 1998 · 2.6K citations · Full text